Pharmacogenetics Testing (PGx)

Pharmacogenetic testing (PGx) can help identify small changes in a patient’s DNA that may be responsible for alterations in prescription drug response. Recent studies have indicated that PGx testing has not only improved patient outcomes but also lowered related health care costs by reducing the number of adverse drug reactions (ADRs).

The Stone Way

Stone Clinical Laboratories offers comprehensive PGx testing to help Clinicians identify each patient’s likely response to their prescription medication. PGx testing helps shift prescribing from reactive to proactive.

  • Quick and efficient cheek swab
  • 7 day turn around time
  • Evidence based and simple to interpret patient results platform

Stone Comprehensive PGx Panel Genes Tested

  • APOE
  • COMT
  • CYP1A2
  • CYP2B6
  • CYP2C19
  • CYP2C9
  • CYP2D6
  • CYP3A4
  • CYP3A5,
  • MTHFR
  • Factor II
  • Factor V
  • OPRM1
  • SLCO1B1
  • VKORC1

Stone Psychiatry PGx Panel Genes Tested

  • CYP2C9
  • CYP2D6
  • CYP3A4
  • CYP3A5
  • CYP1A2
  • OPRM1
  • COMT
  • MTHFR
  • CYP3A5
  • CYP1A2
  • OPRM1
  • COMT
  • MTHFR

PGx Report

Download

Stone Genomics
PGx Requisition

Download

Stone Clinical Laboratories